Abstract:Background and Purpose: Single Small Subcortical Infarction (SSSI) is a subtype of ischemic stroke with unique pathophysiology, often leading to poor outcomes. This study investigates the association between admission hematocrit (HCT) levels and the risk of progressive stroke in SSSI patients. Methods: We conducted a retrospective cohort study using data from the China National Stroke Registry III, including 2,457 SSSI patients. Progressive stroke was defined as an increase in the NIHSS score by 2 points during hospitalization. Logistic regression models assessed the association between HCT levels and progressive stroke risk. Results: Among 2,457 SSSI patients, 135 (5.50%) experienced progressive stroke. Higher HCT levels were independently associated with a lower risk of progressive stroke (adjusted OR 0.983, 95% CI 0.973-0.994, P = 0.002), with a potential dose-response relationship. The protective effect was more pronounced in patients with severe sensory deficits (P for interaction = 0.013) and younger age (<65 years) (P for interaction = 0.037). Lower HCT levels were also independently associated with increased mortality risk within 3 months after stroke (adjusted OR 0.937, 95% CI 0.892-0.984, P < 0.001). Conclusions: Higher admission HCT levels are associated with a lower risk of progressive stroke in SSSI patients, particularly those with severe sensory deficits and younger age. Lower HCT levels may also increase early mortality risk. These findings highlight the importance of monitoring and optimizing HCT levels in SSSI management. Further research should explore the underlying mechanisms and therapeutic implications ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement non ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: IRB approval number: KY2015-001-01 I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data are available upon reasonable request.

Relationships of hematocrit concentration with dementia from a multiethnic population-based study

Low Hemoglobin Levels at Admission Are Independently Associated with Cognitive Impairment after Ischemic Stroke: a Multicenter, Population-Based Study

Associations of blood cell indices and anemia with risk of incident dementia: A prospective cohort study of 313,448 participants

Anemia, hemoglobin concentration and cognitive function in the Longitudinal Ageing Study in India-Harmonized Diagnostic Assessment of Dementia (LASI-DAD) and the Health and Retirement Study

Association between hemoglobin level and cognitive profile in old adults: A cross-sectional survey

The Red Cell Distribution Width and Anemia in Association with Prevalent Dementia

Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging

Association between anemia and cognitive decline among Chinese middle-aged and elderly: evidence from the China health and retirement longitudinal study

WMH Contributions to Cognitive Impairment: Rationale and Design of the Diverse VCID Study

Relation of Hemoglobin to Level of Cognitive Function in Older Persons

Abstract WMP13: The Modifying Effects of Psychosocial Health on the Association Between Cerebrovascular Health and Dementia Risk: The Atherosclerosis Risk in Communities (ARIC) Neurocognitive Study

FC9: Ethno-racial identity and cognitive impairment: A population-based study

Effects of Vascular Risk Factors on the Association of Blood-Based Biomarkers with Alzheimer's Disease

Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort

Associations of resting heart rate with incident dementia, cognition, and brain structure: a prospective cohort study of UK biobank

Cerebral Vasoreactivity, Apolipoprotein E, and the Risk of Dementia: A Population-Based Study

Association of Brain Volumes and White Matter Injury With Race, Ethnicity, and Cardiovascular Risk Factors: The Multi‐Ethnic Study of Atherosclerosis

Brain Structure And Cerebrovascular Risk In Cognitively Impaired Patients Shanghai Community Brain Health Initiative-Pilot Phase

Hemoglobin levels and cognitive trajectory: unveiling prognostic insights in post-stroke geriatric cohort

Abstract WMP16: Multi-Marker Cerebral Small Vessel Disease Score and Risk of Incident Dementia in the Framingham Heart Study

Hematocrit and Progressive Stroke in Single Small Subcortical Infarction: Insights from the China Stroke Registry III